(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. The major components of the myotomal basement membrane are produced in
Myf5nlacZ/nlacZ embryos, but fail to assemble into a
continuous matrix. Whole-mount Myf5nlacZ/+ (A) and
Myf5nlacZ/nLacZ (B) embryos at E9.5 (seen through the
dermomyotome towards the sclerotome), transverse sections of E10.0
Myf5nlacZ/+ (D,F,H) and
Myf5nlacZ/nLacZ embryos (E,E',G,G',I,I')
and longitudinal section of a Myf5nlacZ/nLacZ embryo at
E10.5 (C), immunolabelled for ß-gal and laminin (A-E,E'), type IV
collagen (F,G,G') or perlecan (H,I,I'). (A-E')
Laminin immunoreactivity in Myf5nlacZ/+ embryos shows that
laminin is organised into a sheet-like matrix between the ß-gal-positive
myotomal cells and the mesenchymal sclerotome (arrows in D). In
Myf5nlacZ/nlacZ embryos, laminin-immunoreactivity appears
absent at low magnification (B); at higher magnification, this
immunoreactivity is limited to dots and lines (arrows in C,E,E').
(F-I') The myotomal basement membrane of
Myf5nlacZ/+ embryos also contains collagen type IV (F) and
perlecan (H). In Myf5nlacZ/nlacZ embryos, collagen type IV
(arrows in G) and perlecan (arrows in I) immunoreactivity presents a patchy
organisation, but ß-gal-positive cells are not delimited by this matrix.
Patches of collagen IV and perlecan, are also visible near the dermomyotome
(arrows in G',I'). ep, epaxial; hyp, hypaxial; nt, neural tube.
Scale bars: 100 µm in A-B,D-I'; 50 µm in C.